Gene therapy for tissue regeneration.
Tissue repair and regeneration are the normal biological responses of many different tissues in the body to injury. During the healing process, profound changes occur in cell composition and extracellular matrix (ECM) formation. Fibroblasts and equivalent reparative cells migrate to the wounded area and subsequently proliferate. These cells and reparative cells from the surrounding tissue are responsible for the rapid repair which results in tissue regeneration. Growth factors, one of which is transforming growth factor-beta (TGF-beta), stimulate fibroblasts and smooth muscle cells to proliferate and synthesize ECM proteins. This process of early repair provides a rapid way to restore new tissue and mechanical integrity. This early tissue repair process is normally followed by involution, which requires the production and activation of proteases, tissue maturation and remodeling, reorganization and finally regeneration. Alternately, failure to replace the critical components of the ECM, including elastin and basement membrane, results in abnormal regeneration of the epithelial cell layer. Although remodeling should occur during healing, provisional repair may be followed by excessive synthesis and deposition of collagen, which results in irreversible fibrosis and scarring. This excessive fibrosis which occurs in aberrant healing is at least in part mediated by persistent TGF-beta. Because of the central role of collagen in the wound healing process, the pharmacological control of collagen synthesis has been of paramount importance as a possible way to abrogate aberrant healing and prevent irreversible fibrosis. Fibrosis is an abnormal response to tissue injury.
Cutroneo
Kenneth R
KR
Department of Biochemistry, College of Medicine, University of Vermont, Burlington, Vermont 05405-0068, USA. kenneth.cutroneo@uvm.edu
D000818:Animals; D003094:Collagen / Q000378:metabolism; D005818:Genetic Engineering / Q000379:methods; D015316:Genetic Therapy / Q000379:methods; D006133:Growth Substances / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D020319:Oligodeoxyribonucleotides, Antisense; D020574:Proto-Oncogene Proteins c-sis / Q000235:genetics / Q000494:pharmacology; D012038:Regeneration / Q000235:genetics*; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000502:physiology; D014945:Wound Healing / Q000187:drug effects*
D006133:Growth Substances; D020319:Oligodeoxyribonucleotides, Antisense; D020574:Proto-Oncogene Proteins c-sis; D016212:Transforming Growth Factor beta; D003094:Collagen